GlassScript(Bk5) Azurion 5 M20
Payments companies reported to CMS as associated with (Bk5) Azurion 5 M20. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Bk5) Azurion 5 M20, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Bk5) Azurion 5 M20
These are the largest totals companies reported as associated with (Bk5) Azurion 5 M20. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Vasimahmed Lala | Pontiac, MI | Internal Medicine | $640.56 |
| Thomas Noel | New Albany, IN | Surgery | $251.06 |
| Updesh Bedi | Gretna, LA | Interventional Cardiology | $227.36 |
| Jeffrey Wilson | Fenton, MO | Interventional Cardiology | $166.85 |
| Mahesh Mulumudi | Everett, WA | Interventional Cardiology | $154.52 |
| Joseph Puma | New York, NY | Interventional Cardiology | $143.99 |
| Robert Frankel | Brooklyn, NY | Interventional Cardiology | $143.98 |
| Thomas Wilson | Rapid City, SD | Interventional Cardiology | $142.56 |
| William Reilly | Odessa, TX | Orthopaedic Surgery | $138.80 |
| Matthew Kolek | Atlantis, FL | Clinical Cardiac Electrophysiology | $138.80 |
Prescribed (Bk5) Azurion 5 M20?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.